213225
溴化锂
ReagentPlus®, ≥99%
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
LiBr
化学文摘社编号:
分子量:
86.85
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
231-439-8
MDL number:
Assay:
≥99%
Form:
powder
产品名称
溴化锂, ReagentPlus®, ≥99%
InChI key
AMXOYNBUYSYVKV-UHFFFAOYSA-M
InChI
1S/BrH.Li/h1H;/q;+1/p-1
SMILES string
[Li+].[Br-]
vapor pressure
1 hPa ( 748 °C)
product line
ReagentPlus®
assay
≥99%
form
powder
pH
7 (20 °C, 10 g/L)
mp
550 °C (lit.)
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
溴化锂（LiBr）可用作以下研究的催化剂：
- 通过无溶剂二硫代缩醛反应将（芳族-和α,β-不饱和）醛转化为二硫代缩醛。
- 通过羰基化合物与活性亚甲基化合物的缩合反应合成烯烃。
- β-氨基醇的绿色合成。
- 通过使用LiBr/硝酸铈铵（CAN）试剂系统（作为Br+ 离子来源）进行芳族化合物的化学和区域选择性溴化。
General description
LiBr/三甲基氯硅烷试剂参与醇向溴化物的转换。
Other Notes
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1
存储类别
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Lithium Bromide, an Inexpensive and Efficient Catalyst for Opening of Epoxide Rings by Amines at Room Temperature under Solvent-Free Condition.
Chakraborti AK, et al.
European Journal of Organic Chemistry, 2004(17), 3597-3600 (2004)
An efficient chemo and regioselective oxidative nuclear bromination of activated aromatic compounds using lithium bromide and ceric ammonium nitrate.
Roy SC, et al.
Tetrahedron Letters, 42(39), 6941-6942 (2001)
Lithium bromide as a new catalyst for carbon-carbon bond formation in the solid state.
Prajapati D, et al.
Journal of the Chemical Society. Perkin Transactions 1, 9, 959-960 (1996)
Lithium bromide-catalyzed highly chemoselective and efficient dithioacetalization of α,β-unsaturated and aromatic aldehydes under solvent-free conditions.
Firouzabadi H, et al.
Synthesis, 58-60 (1999)
Eoghan M Cunnane et al.
ACS applied materials & interfaces, 12(24), 26955-26965 (2020-05-23)
Vascular tissue engineering is aimed at developing regenerative vascular grafts to restore tissue function by bypassing or replacing defective arterial segments with tubular biodegradable scaffolds. Scaffolds are often combined with stem or progenitor cells to prevent acute thrombosis and initiate
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持